2. ACT and the Royal College of Paediatrics and Child Health
(RCPCN). Available at:
http://www.act.org.uk. Accessed
March 2008.
3. Murray SA, Kendall M, Boyd K, Sheikh
A. Illness trajectories and palliative care. BMJ. 2005; 330(7498):1007-1011.
4. Lunney JR, Lynn J, Foley DJ, Lipson
S, Guralnik JM. Patterns of functional decline
at the end of life. JAMA. 2003;289(18):2387-2392.
5. Back AL, Arnold RM, Quill TE.
Hope for the best, and prepare for the worst. Ann Intern
Med. 2003;138(5):439-443.
6. Himelstein BP, Hilden JM, Boldt AM, Weissman D. Pediatric
Palliative Care. N Engl J Med. 2004;350(17):1752-1762.
7. Mack JW, Wolfe J. Early integration
of pediatric palliative care: for some children, palliative care starts
at diagnosis. Curr Opin Pediatr. 2006;18 (1): 10-14.
8. Golan H, Bielorai B, Grebler D, Izraeli S, Rechavi G, Toren
A. Integration of a palliative and terminal care center into a comprehensive pediatric
oncology department. Pediatr Blood Cancer. 2008;50(5):949-955.
9. Graham RJ, Robinson WM. Integrating palliative care into
chronic care for children with severe neurodevelopmental disabilities. J
Dev Behav Pediatr. 2005;26(5):361-365.
10. Davies B, Sehring SA, Partridge
JC, et al. Barriers to palliative care for children: perceptions of
pediatric health care providers. Pediatrics. 2008;
121(2):282-288.
11. Wolfe J, Klar N, Grier HE,
et al. Understanding of prognosis among parents of children who
died of cancer: impact on treatment goals and integration of palliative
care. JAMA. 2000;284(19):2469-2475.
12. Mack JW, Wolfe J, Grier HE, Cleary
PD, Weeks JC. Communication about prognosis between
parents and physicians of children with cancer: parent preferences
and the impact of prognostic information. J Clin
Oncol. 2006;24(33):5265-5270.
13. Mack JW, Wolfe J, Cook EF, Grier
HE, Cleary PD, Weeks JC. Hope and prognostic
disclosure. J Clin Oncol. 2007;25(35):5636-5642.
14. Mack JW, Hilden JM, Watterson
J, et al. Parent and physician perspectives on quality of
care at the end of life in children with cancer. J Clin Oncol. 2005;23(36):9155-9161.
15. Valdimarsdóttir U, Kreicbergs U, Hauksdóttir A,
et al. Parents’ intellectual and emotional awareness of
their child’s impending death to cancer: a population-based
long-term follow-up study. Lancet Oncol. 2007;8(8):706-714.
16. Weeks JC, Cook EF, O’Day SJ, et al. Relationship
between cancer patients’ predictions of prognosis and their
treatment preferences. JAMA. 1998;279(21):1709-1714.
17. Morita T, Akechi T, Ikenaga M, et al. Late referrals to
specialized palliative care service in Japan. J Clin Oncol.
2005;23(12):2637-2644.
18. Stromgren AS, Sjogren P, Goldschmidt D, et al. A longitudinal
study of palliative care: patient-evaluated outcome and impact of
attrition. Cancer. 2005;103(8):1747-1755.
19. Mack J, Wolfe J, Grier HE, Cleary PD, Weeks JC. Understanding
of prognosis among parents of children with cancer: Parental optimism
and the parent-physician interaction. J Clin Oncol. 2007;25(11):1357-1362.
20. Patja K, Iivanainen M, Vesala
H, Oksanen H, Ruoppila I. Life expectancy
of people with intellectual disability: a 35-year follow-up study. J Intellect
Disabil Res. 2000;44(Pt 5):591-599.
21. Patja K, Mölsä P, Iivanainen
M. Cause-specific mortality of people with intellectual disability in
a population-based, 35-year follow-up study. J Intellect
Disabil Res. 2001;45(Pt 1):30-40.
22. Hutton JL, Pharoah PO. Life expectancy
in severe cerebral palsy. Arch Dis Child. 2006;91(3):254-258.
23. Hemming K, Hutton JL, Pharoah
PO. Long-term survival for a cohort of adults with cerebral
palsy. Dev Med Child Neurol. 2006;48(2):90-95.
24. Strauss D, Cable W, Shavelle
R. Causes of excess mortality in cerebral palsy. Dev
Med Child Neurol. 1999;41(9):580-585.
25. Katz RT. Life expectancy for children with cerebral
palsy and mental retardation: implications for life care planning. NeuroRehabilitation. 2003;18(3):261-270.
26. Nielsen JD, Uldall PV, Rasmussen
S, Topp MW. Survival of children born with cerebral
palsy. Children born 1971-1986. Ugeskr Laeger. 2002;164
(48):5640-5643. (abstract)
27. American Academy of Pediatrics. Committee on Bioethics and
Committee on Hospital Care. Palliative care for children. Pediatrics. 2000;106(2
Pt 1):351-357.
28. Klick JC, Ballantine A. Providing
care in chronic disease: the ever-changing balance of integrating
palliative and restorative medicine. Pediatr
Clin North Am. 2007;54(5):799-812.
29. Gade G, Venohr I, Conner D,
et al. Impact of an inpatient palliative care team: a randomized control
trial. J Palliat Med. 2008;11(2):180-190.
30. Bluebond-Langner, M., Belasco, J. B., Goldman, A.,
Belasco, C. Understanding parents’ approaches to care and
treatment of children with cancer when standard therapy has failed. J
Clin Oncol. 2007;25(17):2414-2419.
31. Kebudi R, Gorgun O, Ayan I. Oral etoposide for recurrent/progressive
sarcomas of childhood. Pediatr Blood Cancer. 2004;42(4):320-324.
32. Schiavetti A, Varrasso G, Maurizi P, et al. Ten-day schedule
oral etoposide therapy in advanced childhood malignancies.
J
Pediatr Hematol Oncol. 2000; 22(2):119-124.
[PubMed: 10779024]
33. Mathew P, Ribeiro RC, Sonnichsen D, et al. Phase I study
of oral etoposide in children with refractory solid tumors. J
Clin Oncol. 1994;12(7):1452-1457.
34. Sandri A, Massimino M, Mastrodicasa L, et al. Treatment
with oral etoposide for childhood recurrent ependymomas. J
Pediatr Hematol Oncol. 2005;27(9):486-490.
35. Ashley DM, Meier L, Kerby T, et al. Response of recurrent
medulloblastoma to low-dose oral etoposide. J Clin Oncol.
1996;14(6):1922-1927.
36. Donfrancesco A, Jenkner A, Castellano A, et al. Ifosfamide/carboplatin/etoposide
(ICE) as front-line, topotecan/cyclophosphamide as second-line and
oral
temozolomide as third-line treatment for advanced neuroblastoma
over one year of age.
Acta Paediatr Suppl. 2004;93(445):6-11.
37. Shah S, Weitman S, Langevin AM, Bernstein M, Furman W, Pratt
C. Phase I therapy trials in children with cancer. J Pediatr
Hematol Oncol. 1998;20(5):431-438.
38. Daugherty C, Ratain MJ, Grochowski E, et al. Perceptions
of cancer patients and their physicians involved in phase I trials. J
Clin Oncol. 1995;13(5):1062-1072.
39. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J,
Gandara DR. Simultaneous care: a model approach to the perceived
conflict between investigational therapy and palliative care. J Pain
Symptom Manage. 2004;28(6):548-556.
40. Ulrich CM, Grady C, Wendler D. Palliative care: a supportive
adjunct to pediatric phase I clinical trials for anticancer agents? Pediatrics.
2004;114(3): 852-855.
41. Dy S, Lynn J. Getting services right for those sick enough
to die. BMJ. 2007;334(7592):511-513.
42. Shavelle R, Reynolds R, Rosenbloom
L, Day S. Survival in cerebral palsy in the last
20 years: signs of improvement? Dev Med Child Neurol. 2007;49(2):86-92.
43. Sleigh G, Brocklehurst P. Gastrostomy feeding in cerebral
palsy: a systematic review. Arch Dis Child. 2004;89(6):534-539.
44. Finucane TE, Christmas C, Travis
K. Tube feeding in patients with advanced dementia: a review of
the evidence. JAMA. 1999;282(14):1365-70.
45. Morton RE, Wheatley R, Minford J. Respiratory tract infections
due to direct and reflux aspiration in children with severe neurodisability. Dev
Med Child Neurol. 1999;41(5):329-334.
46. Jolley SG, Herbst JJ, Johnson DG, Matlak ME, Book LS. Surgery
in children with gastroesophageal reflux and respiratory symptoms. J
Pediatr. 1980;96(2):194-198.
47. Kawahara H, Okuyama H, Kubota A, et al. Can laparoscopic
antireflux surgery improve the quality of life in children with
neurologic and neuromuscular handicaps? J Pediatr Surg. 2004;39(12): 1761-1764.
48. Cheung KM, Tse HW, Tse PW, Chan KH. Nissen fundoplication
and gastrostomy in severely neurologically impaired children with
gastroesophageal reflux. Hong Kong Med J. 2006;12(4):282-288.
49. Bui HD, Dang CV, Chaney RH, Vergara LM. Does gastrostomy
and fundoplication prevent aspiration pneumonia in mentally retarded
persons? Am J Ment Retard. 1989;94(1):16-19.
50. Carron JD, Derkay CS, Strope GL, Nosonchuk JE, Darrow DH.
Pediatric tracheotomies: changing indications and outcomes. Laryngoscope.
2000;110(7):1099-1104.
51. Vijayasekaran S, Unal R, Schraff SA, Johnson RF, Rutter
MJ. Salivary gland surgery for chronic pulmonary aspiration in children. Int
J Pediatr Otorhinolaryngol. 2007;71(1):119-123.
52. Levetown M;American Academy of Pediatrics Committee
on Bioethics. Communicating with children and families: from
everyday interactions to skill in conveying distressing information. Pediatrics. 2008;121(5):e1441-1460.
53. Hinds PS, Drew D, Oakes LL, et al. End-of-life care
preferences of pediatric patients with cancer. J Clin Oncol. 2005;23(36):9146-9154.
54. Nitschke R, Humphrey GB, Sexauer CL, Catron B, Wunder S,
Jay S. Therapeutic choices made by patients with end-stage cancer. J
Pediatr. 1982;101(3):471-476.
55. Sourkes BM. Armfuls of Time: The Psychological Experience
of the Child with a Life-Threatening Illness. Pittsburgh,
PA: University of Pittsburgh Press; 1995.
56. Davies B, Brenner P, Orloff S, Sumner L, Worden W. Addressing
spirituality in pediatric hospice and palliative care. J
Palliat Care. 2002;18(1):59-67.
57. Thayer P. Spiritual care of children and parents. In: Armstrong-Dailey
A, Zarbock S, eds. Hospice Care for Children. New
York, NY: Oxford University Press; 2001:172-189.
58. Hufton E. Parting gifts: the spiritual needs of children. J
Child Health Care. 2006;10(3):240-250.
59. Walsh K, King M, Jones L, Tookman A, Blizard R. Spiritual
beliefs may affect outcome of bereavement: prospective study.
BMJ. 2002;324(7353):
1551.
[PubMed: 12089091]
60. Kenyon B. Current research in children’s conceptions
of death: a critical review. Omega J Death
Dying. 2001;43:63-91.
61. Wolfe J, Grier HE, Klar N,
et al. Symptoms and suffering at the end of life in children with
cancer. N Engl J Med. 2000;342(5):326-333.
62. Jalmsell L, Kreicbergs U, Onelöv
E, Steineck G, Henter JI. Symptoms affecting
children with malignancies during the last month of life: a nationwide
follow-up. Pediatrics. 2006;117(4): 1314-1320.
63. Drake R, Frost J, Collins JJ.
The symptoms of dying children. J Pain Symptom
Manage. 2003; 26(1):594-603.
64. Hunt AM. A survey of signs, symptoms
and symptom control in 30 terminally ill children. Dev
Med Child Neurol. 1990;32(4):341-346.
65. Hunt A, Burne R. Medical and nursing
problems of children with neurodegenerative disease. Palliat
Med. 1995;9(1):19-26.
66. Beyer JE, Aradine CR. Content validity of an instrument
to measure young children’s perceptions of the intensity
of their pain. J Pediatr Nurs. 1986;1(6):386-395.
67. Wong DL, Hockenberry-Eaton M, Wilson D, Winkelstein ML,
Schwartz P, eds. Wong’s Essentials of Pediatric
Nursing. Vol 6. St Louis, MO: CV Mosby; 2001.
68. Berde C, Wolfe J. Pain, anxiety, distress,
and suffering: interrelated, but not interchangeable. J Pediatr. 2003;142(4):361-363.
69. Defrin R, Lotan M, Pick CG.
The evaluation of acute pain in individuals with cognitive impairment:
a differential effect of the level of impairment. Pain. 2006;124(3):312-20.
70. Voepel-Lewis T, Malviya S, Tait
AR, et al. A comparison of the clinical utility of pain assessment
tools for children with cognitive impairment. Anesth Analg. 2008;106(1):72-78.
71. Voepel-Lewis T, Merkel S, Tait
AR, Trzcinka A, Malviya S. The reliability
and validity of the Face, Legs, Activity, Cry, Consolability observational tool
as a measure of pain in children with cognitive impairment. Anesth
Analg. 2002;95(5):1224-1229.
72. Malviya S, Voepel-Lewis T, Burke
C, Merkel S, Tait AR. The revised FLACC
observational pain tool: improved reliability and validity for pain
assessment in children with cognitive impairment. Paediatr
Anaesth. 2006;16(3):258-265.
73. Breau LM, Camfield C, McGrath
PJ, Rosmus C, Finley GA. Measuring pain
accurately in children with cognitive impairments: refinement of
a caregiver scale. J Pediatr. 2001;138(5):721-727.
74. Breau LM, McGrath PJ, Camfield
CS, Finley GA. Psychometric properties of the non-communicating
children’s pain checklist-revised. Pain. 2002;99(1-2):349-357.
75. Hunt A, Wisbeach A, Seers K,
et al. Development of the paediatric pain profile: role of video
analysis and saliva cortisol in validating a tool to assess pain
in children with severe neurological disability. J Pain
Symptom Manage. 2007;33(3):276-289.
76. Hunt A, Goldman A, Seers K,
et al. Clinical validation of the paediatric pain profile. Dev Med
Child Neurol. 2004;46(1):9-18.
77. Solodiuk J, Curley MA. Pain assessment in nonverbal children
with severe cognitive impairments: the Individualized Numeric Rating
Scale (INRS). J Pediatr Nurs. 2003;18(4):295-299.
78. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al.
Pain in children and adolescents: a common experience. Pain.
2000;87(1):51-58.
79. Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence
of pain in children with severe cognitive impairments. Arch
Pediatr Adolesc Med. 2003;157(12):1219-1226.
80. Houlihan CM, OíDonnell M, Conaway M, Stevenson
RD. Bodily pain and health-related quality of life in children with
cerebral palsy.
Dev Med Child Neurol. 2004;46:305-310.
[PubMed: 15132260]
81. Stallard P, Williams L, Lenton S, Velleman R. Pain in cognitively
impaired, non-communicating children. Arch Dis Child. 2001;85(6):460-462.
82. Greco C, Berde CB. Pain management for the hospitalized
pediatric patient.
Pediatr Clin NorthAm. 2005;52:995-1027.
[PubMed: 16009254]
83. Schechter, NL, Berde, CB, Yaster M, eds. Pain in
Infants, Children, and Adolescents. 2nd ed. Philadelphia,
PA: Lippincott Williams and Wilkins; 2003:599-619.
84. Breau LM, Camfield CS, McGrath PJ, Finley GA. Risk factors
for pain in children with severe cognitive impairments. Dev
Med Child Neurol. 2004;46(6):364-371.
85. Hauer J, Wical B, Charnas L.
Gabapentin successfully manages
chronic unexplained irritability in children with severe neurologic
impairment.
Pediatrics. 2007;119(2):e519-e522.
86. Berde CB, Sethna NF. Analgesics for
the treatment of pain in children. N Engl J Med. 2002;347(14):1094-1103.
87. Friedrichsdorf SJ, Kang TI. The management
of pain in children with life-limiting illnesses. Pediatr
Clin North Am. 2007;54(5):645-672.
88. Goldman A, Hain R, Liben S, eds. Oxford Textbook
of Palliative Care for Children, Oxford: Oxford University
Press; 2006.
89. Moryl N, Coyle N, Foley KM.
Managing an acute pain crisis in a patient with advanced cancer: “this
is as much of a crisis as a code.” JAMA. 2008;299(12):1457-1467.
90. Williams DG, Patel A, Howard
RF. Pharmacogenetics of codeine metabolism in an urban population
of children and its implications for analgesic reliability. Br
J Anaesth. 2002;89(6):839-845.
91. Murphy EJ. Acute pain management pharmacology for the
patient with concurrent renal or hepatic disease. Anaesth
Intensive Care. 2005;33 (3):311-322.
92. Dean M. Opioids in renal failure and dialysis patients. J Pain
Symptom Manage. 2004;28(5):497-504.
93. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and
survival at the end of life: a survey of a hospice population. J
Pain Symptom Manage. 2006;32(6):532-540.
94. Kelly K. Complementary and alternative medical therapies
for children with cancer.
Eur J Cancer. 2004;40:2041-2046.
[PubMed: 15341976]
95. Ott MJ. Mindfulness meditation in pediatric clinical practice. Pediatr
Nurs. 2002;28(5):487-490.
96. Zeltzer LK, Tsao JC, Stelling C, Powers M, Levy S, Waterhouse
M. A phase I study on the feasibility and acceptability of an acupuncture/hypnosis
intervention for chronic pediatric pain. J Pain Symptom
Manage. 2002;24(4):437-446.
97. Tsao JC, Meldrum M, Kim SC, Jacob MC, Zeltzer L.K. Treatment
preferences for CAM in children with chronic pain. Evid
Based Complement Alternat Med. 2007;4(3):367-374.
98. Mertens AC, Sencer S, Myers C, et al. Complementary and
alternative therapy use in adult survivors of childhood cancer:
a report from the Childhood Cancer Survivor Study. Pediatr Blood
Cancer. 2008;50(1):90-97.
99. Post-White J, Hawks R, O’Mara A, Ott MJ. Future
directions of CAM research in pediatric oncology. J Pediatr
Oncol Nurs. 2006;23(5):265-268.
100. Tsao JC, Zeltzer L. Complementary and alternative medicine
approaches for pediatric pain: A review of the state-of-the-science. Evid
Based Complement Alternat Med. 2005;2(2):149-159.
101. Richardson J, Smith JE, McCall G, Pilkington K. Hypnosis
for procedure-related pain and distress in pediatric cancer patients:
a systematic review of effectiveness and methodology related to
hypnosis interventions. J Pain Symptom Manage. 2006;31(1):70-84.
102. Siden H, Nalewajek . High dose opioids
in pediatric palliative care. J Pain Symptom
Manage. 2003;25(5):397-399.
103. Bruera E, Sweeney C. Methadone
use in cancer patients with pain: a review. J Palliat Med. 2002; 5(1):127-138.
104. Bausewein C, Farquhar M, Booth
S, Gysels M, Higginson IJ. Measurement
of breathlessness in advanced disease: a systematic review. Respir Med. 2007;101(3):399-410.
105. Campbell, M.L. Psychometric testing of a respiratory distress
observation scale. J Palliat Med. 2008;11(1):44-50.
106. Lorenz KA, Lynn J, Dy SM,
et al. Evidence for improving palliative care at the
end of life: a systematic review. Ann Intern Med.
2008;148(2): 147-159.
107. Qaseem A, Snow V, Shekelle P, et al. Evidence-based
interventions to improve the palliative care of pain, dyspnea, and
depression at the end of life: a clinical practice guideline from
the American College of Physicians. Ann Intern Med. 2008;148(2):141-146
108. Abernethy AP, Currow DC, Frith
P, Fazekas BS, McHugh A, Bui C.
Randomised, double blind, placebo controlled crossover trial of
sustained release
morphine for the management of refractory dyspnoea.
BMJ.
2003;327(7414):523-528.
109. Clemens KE, Klaschik E. Symptomatic
therapy of dyspnea with strong opioids and its effect on ventilation
in palliative care patients. J Pain Symptom Manage. 2007;33(4):473-481.
110. Allen S, Raut S, Woollard J, Vassallo
M. Low dose diamorphine reduces breathlessness without causing
a fall in oxygen saturation in elderly patients with end-stage idiopathic
pulmonary fibrosis. Palliat Med. 2005;19(2):128-130.
111. Mazzocato C, Buclin T, Rapin CH. The effects
of
morphine on dyspnea and ventilatory function in elderly patients
with advanced cancer: A randomized double-blind controlled trial.
Ann Oncol.
1999;10(12):1511-1514.
112. Ripamonti C. Management of dyspnea in advanced cancer patients. Support
Care Cancer. 1999;7(4):233-243.
113. Seddon PC, Khan Y. Respiratory problems in children with
neurological impairment.
Arch Dis Child. 2003;88:75-78.
[PubMed: 12495971]
114. Wright RE, Wright FR, Carson CA. Videofluoroscopic assessment
in children with severe cerebral palsy presenting with dysphagia.
Pediatr Radiol.
1996;26:720-722.
[PubMed: 8805604]
115. Mirrett PL, Riski JE, Glascott J, Johnson V. Videofluoroscopic
assessment of dysphagia in children with severe cerebral palsy.
Dysphagia. 1994;9:174-179.
[PubMed: 8082326]
116. Taniguchi MH, Moyer RS. Assessment of risk factors for
pneumonia in dysphagic children: Significance of videofluoroscopic
swallowing evaluation.
Dev Med Child Neurol. 1994;36:495-502.
[PubMed: 8005360]
117. Hauer JM. Respiratory symptom management in a
child with severe neurologic impairment. J Palliat Med. 2007;10(5):1201-1207.
118. Brook I, Finegold SM. Bacteriology of aspiration pneumonia
in children. Pediatrics. 1980;65(6): 1115-1120.
119. Dreyfuss D. Aspiration Pneumonia (letter).
N Engl
J Med. 2001;344(24):1868.
[PubMed: 11407356]
120. Brook I. Treatment of aspiration or tracheostomy-associated
pneumonia in neurologically impaired children: effect of antimicrobials
effective against anaerobic bacteria. Int J Pediatr Otorhinolaryngol.
1996;35(2):171-177.
121. Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H. Ampicillin + sulbactam
vs
clindamycin +/ñ cephalosporin for
the treatment of aspiration pneumonia and primary lung abscess.
Clin Microbiol
Infect. 2004;10(2):163-170.
122. Kadowaki M, Demura Y, Mizuno S, et al. Reappraisal of
clindamycin
IV monotherapy for treatment of mild-to-moderate aspiration pneumonia
in elderly patients.
Chest. 2005;127(4):1276-1282.
123. Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal
manifestations in children with cerebral palsy. Brain Dev. 1999;21(5):307-311.
124. Richards CA, Milla PJ, Andrews
PL, Spitz L. Retching and vomiting in neurologically impaired
children after fundoplication: predictive preoperative factors. J Pediatr
Surg. 2001 Sep;36(9):1401-1404.
125. Antao B, Ooi K, Ade-Ajayi N, Stevens
B, Spitz L. Effectiveness of alimemazine in controlling retching
after Nissen fundoplication. J Pediatr Surg. 2005;40(11):1737-1740.
126. Richards CA, Andrews PL, Spitz
L, Milla PJ. Nissen fundoplication may induce gastric
myoelectrical disturbance in children. J Pediatr
Surg. 1998;33(12):1801-1805.
127. Santucci G, Mack JW. Common gastrointestinal symptoms
in pediatric palliative care: nausea, vomiting, constipation, anorexia,
cachexia. Pediatr Clin North Am. 2007;54(5):673-689.
128. Baines MJ. ABC of palliative care. Nausea, vomiting,
and intestinal obstruction. BMJ. 1997;315 (7116):1148-1150.
129. Wood GJ, Shega JW, Lynch B, Von
Roenn JH. Management of intractable nausea and vomiting in
patients at the end of life: “I was feeling nauseous all
of the time . . nothing was working.” JAMA. 2007;298(10):1196-1207.
130. Fallon M, O’Neill B. ABC of palliative care. Constipation
and diarrhoea. BMJ. 1997;315 (7118): 1293-1296.
131. Mancini I, Bruera E. Constipation in advanced cancer patients. Support
Care Cancer. 1998;6(4): 356-364.
132. Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced
constipation and analgesia. J Pain Symptom Manage.
2002;23(1):48-53.
133. Sykes NP. An investigation of the ability of oral naloxone
to correct opioid-related constipation in patients with advanced
cancer. Palliat Med. 1996;10(2):135-144.
134. Ripamonti C, Bruera E. Palliative management of malignant
bowel obstruction. Int J Gynecol Cancer. 2002;12(2):135-143.
135. Laval G, Girardier J, Lassauniere JM, Leduc B, Haond C,
Schaerer R. The use of steroids in the management of inoperable
intestinal obstruction in terminal cancer patients: do they remove
the obstruction? Palliat Med. 2000;14(1):3-10.
136. Ripamonti C, Mercadante S, Groff L, Zecca E, De Conno F,
Casuccio A. Role of octreotide,
scopolamine butylbromide, and hydration
in symptom control of patients with inoperable bowel obstruction
and nasogastric tubes: a prospective randomized trial.
J
Pain Symptom Manage. 2000;19(1):23-34.
137. Bruera E, Sweeney C. Cachexia and asthenia in cancer patients.
Lancet
Oncol. 2000;1:138-147.
[PubMed: 11905651]
138. Bruera E. ABC of palliative care. Anorexia, cachexia, and
nutrition. BMJ. 1997;315(7117): 1219-1222.
139. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of
weight loss prior to chemotherapy in cancer patients. Eastern Cooperative
Oncology Group. Am J Med. 1980;69(4):491-497.
140. Koretz RL. Parental nutrition: is it oncologically logical? J
Clin Oncol. 1984;2(5):534-538.
141. Klein S, Koretz RL. Nutrition support in patients with
cancer: what do the data really show? Nutr Clin Pract.
1994;9(3):91-100.
142. Bachmann P, Marti-Massoud C, Blanc-Vincent MP, et al. Summary
version of the Standards, Options and Recommendations for palliative
or terminal nutrition in adults with progressive cancer (2001). Br
J Cancer. 2003;89 Suppl 1:S107-110.
143. Torelli GF, Campos AC, Meguid MM. Use of TPN in terminally
ill cancer patients. Nutrition. 1999;15(9):665-667.
144. De Conno F, Martini C, Zecca E, et al.
Megestrol acetate
for anorexia in patients with far-advanced cancer: a double-blind
controlled clinical trial.
Eur J Cancer. 1998;34(11):1705-1709.
145. Orme LM, Bond JD, Humphrey MS, et al.
Megestrol acetate
in pediatric oncology patients may lead to severe, symptomatic adrenal
suppression.
Cancer. 2003;98(2):397-405.
146. Hinds PS, Hockenberry-Eaton M, Gilger E, et al. Comparing
patient, parent, and staff descriptions of fatigue in pediatric
oncology patients. Cancer Nurs. 1999;22(4):277–288,
quiz 88–89.
147. Bouffet E, Zucchinelli V, Costanzo P, Blanchard P. Schooling
as a part of palliative care in paediatric oncology. Palliat
Med. 1997;11(2):133-139.
148. Gibson F, Garnett M, Richardson A, Edwards J, Sepion B.
Heavy to carry - A survey of parents’ and healthcare professionals’ perceptions
of cancer-related fatigue in children and young people. Cancer
Nurs. 2005;28(1):27-35.
149. Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative
care–Part II: cachexia/anorexia and fatigue. J
Palliat Med. 2006;9(2):409-421.
150. Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL in pediatric
cancer: reliability and validity of the Pediatric Quality of Life
Inventory Generic Core Scales, Multidimensional Fatigue Scale, and
Cancer Module. Cancer. 2002;94(7) :2090–2106.
151. Hockenberry MJ, Hinds PS, Barrera P, et al. Three instruments
to assess fatigue in children with cancer: the child, parent and
staff perspectives.
J Pain Symptom Manage. 2003;25(4):319–328.
[PubMed: 12691683]
152. Bruera E, Driver L, Barnes EA, et al. Patient-controlled
methylphenidate for the management of fatigue in patients with advanced
cancer: a preliminary report.
J Clin Oncol. 2003;21(23):4439-4443.
153. Ullrich CK, Mayer OH. Assessment
and management of fatigue and dyspnea in pediatric palliative care. Pediatr
Clin North Am. 2007;54(5):735-756.
154. Collins JJ, Byrnes ME, Dunkel IJ, et al. The measurement
of symptoms in children with cancer. J Pain Symptom Manage.
2000;19(5):363-377.
155. Collins JJ, Devine TD, Dick GS, et al. The measurement
of symptoms in young children with cancer: the validation of the
Memorial Symptom Assessment Scale in children aged 7-12. J
Pain Symptom Manage. 2002;23(1):10-16.
156. Woodgate RL, Degner LF, Yanofsky R. A different perspective
to approaching cancer symptoms in children. J Pain Symptom
Manage. 2003;26(3): 800-817.
157. Dejong M, Fombonne E. Depression in paediatric cancer:
an overview.
Psychooncology. 2006; 15(7):553-566.
[PubMed: 16355435]
158. Theunissen JM, Hoogerbrugge PM, van Achterberg T, Prins
JB, Vernooij-Dassen MJ, van den Ende CH. Symptoms in the palliative
phase of children with cancer.
Pediatr Blood Cancer. 2007;
49(2):160-165.
[PubMed: 16972239]
159. Bennett DS. Depression among children with chronic medical
problems—a meta-analysis. J Pediatr Psychol.
1994;19(2):149-169.
160. Goldman A, Hewitt M, Collins GS, Childs M, Hain R. Symptoms
in children/young people with progressive malignant disease:
United Kingdom Children’s Cancer Study Group/Paediatric
Oncology Nurses Forum survey. Pediatrics. 2006;117(6):e1179-1186.
161. Woodgate RL, Degner LF. Expectations and beliefs about
children’s cancer symptoms: perspectives of children with
cancer and their families. Oncol Nurs Forum. 2003;30(3):479-491.
162. Katz ER, Jay S. Psychological aspects of cancer in children,
adolescents, and their families. Clin Psychol Rev.
1984;4(5):525-542.
163. Szyndler JE, Towns SJ, van Asperen
PP, McKay KO. Psychological and family functioning
and quality of life in adolescents with cystic fibrosis. J Cyst
Fibros. 2005;4(2):135-144.
164. Pfeffer PE, Pfeffer JM, Hodson
ME. The psychosocial and psychiatric side of cystic fibrosis
in adolescents and adults. J Cyst Fibros. 2003; 2(2):61-68.
165. Roccella M, Pace R, De Gregorio
MT. Psychopathological assessment in children affected by Duchenne
de Boulogne muscular dystrophy. Minerva Pediatr. 2003;55(3):267-276.
166. Goodenough B, Hardy J, Jarratt R. “Riding my manta
ray with Uncle Fester”: hypnosis for managing pain and
distress in a dying child. Australian J Clin Exp Hypnosis.
2003;31(2):95-102.
167. Gothelf D, Rubinstein M, Shemesh E, et al. Pilot study:
fluvoxamine treatment for depression and anxiety disorders in children
and adolescents with cancer. J Am Acad Child Adolesc Psychiatry.
2005;44(12):1258-1262.
168. Portteus A, Ahmad N, Tobey D, Leavey P. The prevalence
and use of antidepressant medication in pediatric cancer patients. J
Child Adolesc Psychopharmacol. 2006;16(4):467-473.
169. Elgudin L, Kishan S, Howe D.
Depression in children and adolescents with cystic fibrosis: case
studies. Int J Psychiatry Med. 2004;34(4):391-397.
170. Pereira J, Bruera E. Depression with psychomotor retardation:
diagnostic challenges and the use of psychostimulants.
J
Palliat Med. 2001;4(1):15–21.
[PubMed: 11291390]
171. Homsi J, Walsh D, Nelson KA, LeGrand S, Davis M.
Methylphenidate
for depression in hospice practice: a case series.
Am J
Hosp Palliat Care. 2000;17(6):393-398.
172. Del Fabbro E, Dalal S, Bruera
E. Symptom control in palliative care–Part III: dyspnea
and delirium. J Palliat Med. 2006;9(2):422-436.
173. Inouye SK. Delirium in older persons. N Engl
J Med. 2006;354(11):1157-1165.
174. Leentjens AF, Schieveld JN, Leonard
M, Lousberg R, Verhey FR, Meagher
DJ. A comparison f the phenomenology of pediatric, adult,
and geriatric delirium. J Psychosom Res. 2008;64(2):219-223.
175. Turkel SB, Trzepacz PT, Tavaré CJ.
Comparing symptoms of delirium in adults and children. Psychosomatics. 2006;47(4):320-324.
176. Franck LS, Johnson LM, Lee K, et al. Sleep disturbances
in children with human immunodeficiency virus infection. Pediatrics.
1999;104(5): e62.
177. Rees DC, Olujohungbe AD, Parker NE, et al. Guidelines for
the management of the acute painful crisis in sickle cell disease. Br
J Haematol. 2003;120(5):744-752.
178. Shapiro BS, Dinges DF, Orne EC, et al. Home management
of sickle cell-related pain in children and adolescents: natural
history and impact on school attendance. Pain. 1995;61(1):139-144.
179. Kvale EA, Shuster JL. Sleep disturbance in supportive care
of cancer: A review. J Palliat Med. 2006;9(2):437-450.
180. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances
in oncology outpatients receiving radiation therapy for bone metastasis:
a pilot study. J Pain Symptom Manage. 1999;17(5):320-332.
181. Palermo TM, Kiska R. Subjective sleep disturbances in adolescents
with chronic pain: relationship to daily functioning and quality
of life. J Pain. 2005;6(3):201-207.
182. Savard J, Morin CM. Insomnia in the context of cancer:
a review of a neglected problem. J Clin Oncol.
2001;19(3):895-908.
183. Dodge NN, Wilson GA. Melatonin for treatment of sleep disorders
in children with developmental disabilities. J Child Neurol. 2001;16(8):581-584.
184. Collins JJ, Kerner J, Sentivany S, Berde CB. Intravenous
amitriptyline in pediatrics. J Pain Symptom Manage. 1995;10(6):471-475.
185. Davis MP. Does trazodone have a role in palliating symptoms? Support
Care Cancer. 2007;15 (2):221-224.
186. Pranzatelli MR, Tate ED, Dukart WS, Flint MJ, Hoffman MT,
Oksa AE. Sleep disturbance and rage attacks in opsoclonus-myoclonus
syndrome: response to trazodone. J Pediatr. 2005;147(3):
372-378.
187. Schnoes CJ, Kuhn BR, Workman EF, Ellis CR. Pediatric prescribing
practices for
clonidine and other pharmacologic agents for children
with sleep disturbance.
Clin Pediatr. 2006;45(3):229-238.
188. Sela RA, Watanabe S, Nekolaichuk CL. Sleep disturbances
in palliative cancer patients attending a pain and symptom control
clinic. Palliat Support Care. 2005;3(1):23-31.
189. Rosenberg RP. Sleep maintenance insomnia: strengths and
weaknesses of current pharmacologic therapies. Ann Clin
Psychiatry. 2006;18(1): 49-56.
190. Monti M, Castellani L, Berlusconi A, Cunietti E. Use of
red blood cell transfusions in terminally ill cancer patients admitted
to a palliative care uni. J Pain Symptom Manage.
1996;12(1):18-22.
191. Pereira J, Phan T. Management of bleeding in patients with
advanced cancer.
Oncologist. 2004; 9(5):561-570.
[PubMed: 15477642]
192. Pereira J, Watanabe S, Wolch G. A retrospective review
of the frequency of infections and patterns of antibiotic utilization
on a palliative care unit. J Pain Symptom Manage.
1998;16(6):374-381.
193. Loblaw DA, Laperriere NJ. Emergency treatment of malignant
extradural spinal cord compression: an evidence-based guideline.
J
Clin Oncol. 1998; 16(4):1613-1624.
[PubMed: 9552073]
194. Abrahm JL. Management of pain and spinal cord compression
in patients with advanced cancer. ACP-ASIM End-of-life Care Consensus
Panel. American College of Physicians-American Society of Internal
Medicine. Ann Intern Med. 1999;131(1):37-46.
195. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive
surgical resection in the treatment of spinal cord compression caused
by metastatic cancer: a randomised trial. Lancet.
2005;366 (9486):643-648.
196. Houlahan KE, Branowicki PA, Mack JW, Dinning C, McCabe
M. Can end of life care for the pediatric patient suffering with
escalating and intractable symptoms be improved? J Pediatr Oncol
Nurs. 2006;23(1):45-51.
197. Anghelescu DL, Oakes LL. Ketamine use for reduction
of opioid tolerance in a 5-year-old girl with end-stage abdominal
neuroblastoma. J Pain Symptom Manage. 2005;30(1):1-3.
198. Tsui BC, Davies D, Desai S, Malherbe
S. Intravenous ketamine infusion as an adjuvant to
morphine
in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
J Pediatr
Hematol Oncol. 2004;26(10):678-680.
199. Klepstad P, Borchgrevink P, Hval
B, Flaat S, Kaasa S. Long-term treatment
with ketamine in a 12-year-old girl with severe neuropathic pain caused
by a cervical spinal tumor. J Pediatr Hematol Oncol. 2001;23(9):616-619.
200. Lo B, Rubenfeld G. Palliative sedation
in dying patients: “we turn to it when everything else hasn’t
worked.” JAMA. 2005;294(14):1810-1816.
201. Krakauer E, Penson RT, Truog RD, King L, Chabner B, Lynch
TJ. Sedation for intractable distress of a dying patient: acute
palliative care and the principle of double effect.
Oncologist. 2000;5:53-62.
[PubMed: 10706650]
202. Cowan JD, Walsh D. Terminal sedation in palliative medicine—definition
and review of the literature.
Support Care Cancer.
2001;9:403-407.
[PubMed: 11585266]
203. Salacz M, Weissman D. Controlled Sedation for Refractory
Suffering: Part II. Fast Facts and Concepts #107.
2004.
204. Tobias JD: Propofol sedation for terminal care in a pediatric
patient.
Clin Pediatr. 1997;36:291–293
[PubMed: 9152556]
205. Casarett D, Kapo J, Caplan A.
Appropriate use of artificial nutrition and hydration—fundamental principles
and recommendations. N Engl J Med. 2005;353(24):2607-2612.
206. Nutrition and hydration: moral and pastoral reflections.
National Conference of Catholic Bishops Committee for Pro-life Activities. J Contemp
Health Law Policy. 1999;15(2):455-477.
207. Stanley AL. Withholding artificially provided nutrition
and hydration from disabled children–assessing their quality
of life. Clin Pediatr. 2000;39(10):575-579.
208. American Academy of Pediatrics Committee on Bioethics:
Guidelines on foregoing life-sustaining medical treatment. Pediatrics. 1994;93(3):532-536.
210. Nelson LJ, Rushton CH, Cranford
RE, Nelson RM, Glover JJ, Truog
RD. Forgoing medically provided nutrition and hydration in
pediatric patients. J Law Med Ethics. 1995;23(1):33-46.
211. Feudtner C, Christakis DA, Zimmerman FJ, Muldoon JH, Neff
JM, Koepsell TD. Characteristics of deaths occurring in children’s
hospitals: implications for supportive care services. Pediatrics. 2002;109(5):887-893.
212. Dussel V, Kreicbergs U, Hilden
JM, et al. Looking beyond where children die: determinants
and effects of planning a child’s location of death. J Pain
Symptom Manage. 2008;37:33-43.
213. De Lima L, Krakauer EL, Lorenz
K, Praill D, Macdonald N, Doyle
D. Ensuring palliative medicine availability: the development
of the IAHPC list of essential medicines for palliative care. J Pain
Symptom Manage. 2007;33(5):521-526.
214. Carroll JM, Torkildson C, Winsness
JS. Issues related to providing quality pediatric palliative care
in the community. Pediatr Clin North Am. 2007;54(5):813-827
215. Hinds PS, Oakes L, Furman W, et al. End-of-life decision
making by adolescents, parents, and healthcare providers in pediatric
oncology: research to evidence-based practice guidelines. Cancer
Nurs. 2001;24(2):122-134, quiz 135-126.
216. Pizzo PA, Poplack DG, eds. Principles and Practice
of Pediatric Oncology. 4th ed. Philadelphia, PA: Lippincott
Williams & Wilkins; 2002.
217. Rando TA. Treatment of Complicated Mourning. Champaign,
IL: Research Press; 1993.
218. Field MJ, Behrman RE, eds. Institute of Medicine (U.S.)
Committee on Palliative and End-of-Life Care for Children and Their
Families. When Children Die: Improving Palliative and End-of-Life
Care for Children and Their Families. Washington, DC: National
Academy Press; 2003.
219. Rando TA. Parental Loss of a Child. Champaign, IL:
Research Press; 1986.
220. Martinson L, Davies B, McClowry S. Parental depression
following the death of a child. Death Studies.
1991;15:359-367.
221. Stroebe M, Hannson R, Stroebe W, Schut H, eds. Handbook
of Bereavement Research: Consequences, Coping, and Care. Washington,
DC: American Psychological Association Press; 2001:2 19-240.
222. Sanders CM. Grief:The Mourning
After: Dealing with Adult Bereavement. New York, NY: John
Wiley & Sons; 1989.
223. Kreicbergs UC, Lannen P, Onelov
E, Wolfe J. Parental grief after losing a child
to cancer: impact of professional and social support on long-term
outcomes. J Clin Oncol. 2007;25:3307-3312.
224. Davies B. Shadows in the Sun: The Experiences of
Sibling Bereavement in Childhood. Philadelphia, PA: Taylor
and Francis; 1999.
225. Martinson I., Campos, R. Adolescent bereavement: Long term
responses to a sibling’s death from cancer. J Adolesc
Res. 1991;7:54-69.
226. Reilly DE, Hastings RP, Vaughan
FL, Huws JC. Parental bereavement and the loss
of a child with intellectual disabilities: a review of the literature. Intellect
Dev Disabil. 2008;46(1):27-43.
227. Contro, NA, Larson J, Scofield S, Sourkes B, Cohen HJ.
Hospital staff and family perspectives regarding quality of pediatric
palliative care. Pediatrics. 2004;114(5):1248-1252.
228. Jones B. Pediatric palliative and end-of-life care: the
role of social work in pediatric oncology. J Soc Work End
Life Palliat Care. 2005;1(4):35-62.
229. Price J, McNeilly P, Surgenor M. Breaking bad news to parents:
the children’s nurse’s role. Int J Palliat
Nurs. 2006;12(3):115-120.
230. Solomon MZ, Sellers DE, Heller KS et al. New and lingering
controversies in pediatric end of life care. Pediatrics.
2005;116(4):872-883.
231. Parker-Raley J, Jones B, Maxson T. Communicating the death
of a child in the emergency department: the negotiation of dialectical
tensions. J Health Qual. 2008.